humans |
237 |
male |
201 |
female |
193 |
adult |
164 |
middle aged |
158 |
hepatocellular carcinoma |
155 |
aged |
139 |
animals |
110 |
medical sciences |
109 |
prognosis |
105 |
chinese |
90 |
recurrence |
87 |
aged, 80 and over |
83 |
covid-19 |
83 |
treatment outcome |
83 |
liver transplantation |
79 |
survival |
78 |
cell line, tumor |
77 |
adolescent |
76 |
apoptosis |
71 |
hong kong |
70 |
mice |
69 |
cell proliferation |
67 |
surgery |
67 |
metastasis |
66 |
reverse transcriptase polymerase chain reaction |
65 |
hong kong - epidemiology |
64 |
time factors |
64 |
survival analysis |
62 |
biomarker |
59 |
immunohistochemistry |
58 |
nasopharyngeal carcinoma |
58 |
colorectal cancer |
57 |
gene expression regulation, neoplastic |
57 |
prospective studies |
56 |
hcc |
53 |
retrospective studies |
53 |
children |
52 |
molecular sequence data |
52 |
neoplasm staging |
52 |
follow-up studies |
49 |
mutation |
49 |
quality of life |
49 |
sars-cov-2 |
49 |
base sequence |
48 |
cancer |
48 |
survival rate |
48 |
genetic predisposition to disease |
46 |
up-regulation |
46 |
gastric cancer |
45 |
child |
44 |
disease progression |
44 |
gene expression |
44 |
promoter regions, genetic |
43 |
cohort studies |
42 |
epidemiology |
42 |
infant |
42 |
oncology |
42 |
blotting, western |
41 |
china |
41 |
dna methylation |
41 |
gastroenterology |
41 |
gene expression profiling |
41 |
mice, nude |
41 |
rats |
41 |
breast cancer |
40 |
child, preschool |
40 |
down-regulation |
40 |
risk factors |
40 |
transfection |
40 |
asian continental ancestry group - genetics |
39 |
hepatectomy |
39 |
liver cancer |
39 |
esophageal squamous cell carcinoma |
38 |
inflammation |
38 |
neoplasm invasiveness |
38 |
age factors |
37 |
case-control studies |
37 |
enzyme-linked immunosorbent assay |
37 |
postoperative complications |
37 |
tumor cells, cultured |
37 |
cell movement |
36 |
chemotherapy |
36 |
esophageal cancer |
36 |
radiotherapy |
35 |
carcinoma |
34 |
disease-free survival |
34 |
asia |
33 |
diagnosis |
33 |
angiogenesis |
32 |
biomarkers |
32 |
case report |
32 |
combined modality therapy |
32 |
controlled study |
32 |
incidence |
32 |
mortality |
32 |
promoter regions, genetic - genetics |
32 |
proteomics |
32 |
rna, messenger - metabolism |
32 |
squamous cell carcinoma |
32 |
biliary atresia |
31 |
cirrhosis |
31 |
gene silencing |
31 |
laparoscopy |
31 |
liver |
31 |
lymphatic metastasis |
31 |
multivariate analysis |
31 |
risk assessment |
31 |
risk factor |
31 |
signal transduction |
31 |
human |
30 |
microrna |
30 |
polymerase chain reaction |
30 |
tomography, x-ray computed |
30 |
asian |
29 |
cytokines |
29 |
dna mutational analysis |
29 |
immunotherapy |
29 |
alleles |
28 |
amino acid sequence |
28 |
cell differentiation |
28 |
chi-square distribution |
28 |
morbidity |
28 |
neoplasm transplantation |
28 |
oligonucleotide array sequence analysis |
28 |
outcome |
28 |
p53 |
28 |
prevalence |
28 |
proliferation |
28 |
transcription, genetic |
28 |
cisplatin |
27 |
dose-response relationship, drug |
27 |
emt |
27 |
gastroenterology medical sciences |
27 |
hepatitis b virus |
27 |
rats, sprague-dawley |
27 |
transarterial chemoembolization |
27 |
cell proliferation - drug effects |
26 |
chemoresistance |
26 |
coronavirus |
26 |
e-cadherin |
26 |
sars-cov |
26 |
asian continental ancestry group |
25 |
epithelial-mesenchymal transition |
25 |
genome-wide association study |
25 |
genotype |
25 |
living donors |
25 |
neoadjuvant therapy |
25 |
rna, messenger - genetics - metabolism |
25 |
wound healing |
25 |
cytology and histology |
24 |
helicobacter pylori |
24 |
hirschsprung disease |
24 |
liver fibrosis |
24 |
mice, inbred balb c |
24 |
neoplasm metastasis |
24 |
polymorphism, single nucleotide - genetics |
24 |
sensitivity and specificity |
24 |
transplantation, heterologous |
24 |
whole-exome sequencing |
24 |
acute disease |
23 |
animal tissue |
23 |
complications |
23 |
genetic association |
23 |
hepatitis b |
23 |
homeodomain proteins - genetics - metabolism |
23 |
ischemic stroke |
23 |
oncology medical sciences |
23 |
polymorphism, single nucleotide |
23 |
radiology and nuclear medicine pharmacy and pharmacology biology |
23 |
reproducibility of results |
23 |
ret |
23 |
single nucleotide polymorphism |
23 |
copy number variation |
22 |
elderly |
22 |
endoscopy |
22 |
glycolysis |
22 |
graft survival |
22 |
infant, newborn |
22 |
liver transplant |
22 |
phosphorylation |
22 |
sorafenib |
22 |
transcription factors - genetics |
22 |
young adult |
22 |
β-catenin |
22 |
cell line |
21 |
double-blind method |
21 |
drug therapy, combination |
21 |
fatal outcome |
21 |
gene expression regulation |
21 |
gene mutation |
21 |
general surgery |
21 |
invasion |
21 |
length of stay |
21 |
medicine & public health |
21 |
nf-κb |
21 |
outcomes |
21 |
pathogenesis |
21 |
tumor markers, biological - blood |
21 |
type 2 diabetes |
21 |
analysis of variance |
20 |
biopsy |
20 |
cancer staging |
20 |
cancer stem cell |
20 |
chemicals and cas registry numbers |
20 |
disease models, animal |
20 |
escc |
20 |
immunosuppression |
20 |
liver cirrhosis |
20 |
magnetic resonance imaging |
20 |
methylation |
20 |
nafld |
20 |
phenotype |
20 |
polymorphism, genetic |
20 |
predictive value of tests |
20 |
prognostic factors |
20 |
stents |
20 |
targeted therapy |
20 |
thyroidectomy |
20 |
treatment |
20 |
tumor recurrence |
20 |
tumorigenesis |
20 |
cancer stemness |
19 |
china - ethnology |
19 |
colon cancer |
19 |
dna primers |
19 |
esophagectomy |
19 |
gene frequency |
19 |
head and neck cancer |
19 |
hepatectomy - methods |
19 |
immunosuppressive agents - therapeutic use |
19 |
liver neoplasms - metabolism - pathology |
19 |
liver resection |
19 |
long-term outcome |
19 |
microsatellite repeats |
19 |
migration |
19 |
nuclear proteins - genetics - metabolism |
19 |
radiofrequency ablation |
19 |
vitamin d |
19 |
adolescents |
18 |
advanced hepatocellular carcinoma |
18 |
animal experiment |
18 |
apoptosis - drug effects |
18 |
body mass index |
18 |
carcinoma, hepatocellular - metabolism - pathology |
18 |
carcinoma, hepatocellular - mortality - pathology - surgery |
18 |
choledochal cyst |
18 |
chronic disease |
18 |
esophageal neoplasms - genetics - metabolism - pathology |
18 |
flow cytometry |
18 |
gene expression regulation, neoplastic - genetics |
18 |
liver neoplasms - genetics - metabolism - pathology |
18 |
liver transplantation - methods |
18 |
major clinical study |
18 |
malignancy |
18 |
mutation - genetics |
18 |
neoplasm recurrence, local - surgery |
18 |
portal vein |
18 |
reoperation |
18 |
resection |
18 |
sex factors |
18 |
syndrome |
18 |
transcription factors - genetics - metabolism |
18 |
tumor suppressor |
18 |
tumor suppressor gene |
18 |
vascular surgery |
18 |
antiviral agents - therapeutic use |
17 |
bile duct atresia |
17 |
blood transfusion |
17 |
brachytherapy |
17 |
cadaver |
17 |
carcinoma, squamous cell - genetics - metabolism - pathology |
17 |
cell adhesion molecules - genetics |
17 |
cells, cultured |
17 |
cholangiocarcinoma |
17 |
cricetinae |
17 |
enzyme inhibitors - pharmacology |
17 |
extracellular vesicles |
17 |
genes, tumor suppressor |
17 |
genetic susceptibility |
17 |
hirschsprung disease - genetics |
17 |
in situ hybridization, fluorescence |
17 |
liver neoplasms - mortality - pathology - surgery |
17 |
liver transplantation - adverse effects |
17 |
meta-analysis |
17 |
microarray |
17 |
next-generation sequencing |
17 |
nf-κb signaling |
17 |
palliative care |
17 |
patient selection |
17 |
pin1 |
17 |
postoperative complications - epidemiology |
17 |
probability |
17 |
replication |
17 |
rna, messenger - genetics |
17 |
transcription factors - metabolism |
17 |
two-hybrid system techniques |
17 |
antigens, cd - genetics |
16 |
antineoplastic agents - therapeutic use |
16 |
association |
16 |
cancer stem cells |
16 |
child psychosocial problems |
16 |
cholangitis |
16 |
chromosome mapping |
16 |
cytoskeletal proteins - genetics |
16 |
diagnosis, differential |
16 |
gist |
16 |
healthcare workers |
16 |
hepatitis |
16 |
hepatocellular carcinoma (hcc) |
16 |
hirschsprung's disease |
16 |
home confinement |
16 |
hospital policies |
16 |
hypoxia |
16 |
immunoenzyme techniques |
16 |
immunoglobulin |
16 |
liver metastasis |
16 |
liver neoplasms - genetics |
16 |
mutations |
16 |
perceived stress |
16 |
pet/ct |
16 |
pregnancy |
16 |
psychological wellbeing |
16 |
school closure |
16 |
sequence analysis, dna |
16 |
severity of illness index |
16 |
statistics, nonparametric |
16 |
survivorship |
16 |
tandem repeat sequences |
16 |
thoracic surgery |
16 |
thyroid cancer |
16 |
transplantation |
16 |
tumor microenvironment |
16 |
ultrasonography |
16 |
abdominal surgery |
15 |
adiponectin |
15 |
anastomosis, surgical |
15 |
animal cell |
15 |
body weight |
15 |
cancer survival |
15 |
carcinoma, hepatocellular - genetics |
15 |
carcinoma, hepatocellular - genetics - metabolism - pathology |
15 |
carcinoma, hepatocellular - mortality - surgery |
15 |
cardiac surgery |
15 |
carrier proteins - metabolism |
15 |
cell transformation, neoplastic - genetics - metabolism |
15 |
chromosome aberrations |
15 |
complication |
15 |
coronary artery disease |
15 |
dna-binding proteins - genetics |
15 |
emergencies |
15 |
enteric nervous system |
15 |
fibrosis |
15 |
gene identification |
15 |
gene locus |
15 |
gene therapy |
15 |
hepatitis b virus - genetics |
15 |
hepatitis b, chronic - complications |
15 |
laparoscopic liver resection |
15 |
liver failure |
15 |
liver neoplasms - mortality - surgery |
15 |
liver neoplasms - pathology - surgery |
15 |
nasopharyngeal neoplasms - genetics - metabolism - pathology |
15 |
neoplasm proteins - genetics |
15 |
neuregulin-1 - genetics |
15 |
oesophageal cancer |
15 |
oesophageal squamous cell carcinoma |
15 |
priority journal |
15 |
proto-oncogene proteins - genetics |
15 |
reference values |
15 |
salvage therapy |
15 |
signal transduction - genetics |
15 |
abdominal pain |
14 |
adjuvant chemotherapy |
14 |
algorithms |
14 |
antineoplastic combined chemotherapy protocols - therapeutic use |
14 |
beta catenin |
14 |
bridging therapy |
14 |
carcinoma, hepatocellular - genetics - metabolism |
14 |
carcinoma, squamous cell - genetics - pathology |
14 |
cell invasion |
14 |
chemoradiotherapy |
14 |
computed tomography |
14 |
coronavirus disease 2019 |
14 |
cytoplasm - metabolism |
14 |
differentiation |
14 |
hepatic resection |
14 |
hospital mortality |
14 |
immune activation |
14 |
intestine |
14 |
intraoperative complications - epidemiology |
14 |
kaplan-meier estimate |
14 |
liver - metabolism |
14 |
liver - pathology |
14 |
liver function tests |
14 |
minimally invasive surgery |
14 |
nasopharyngectomy |
14 |
nucleic acid hybridization |
14 |
pathogenicity |
14 |
peptidyl-prolyl-isomerase |
14 |
prognostic marker |
14 |
proportional hazards models |
14 |
rectal cancer |
14 |
recurrent nasopharyngeal carcinoma |
14 |
review |
14 |
rna interference |
14 |
sars |
14 |
signal transduction - physiology |
14 |
stomach neoplasms - genetics |
14 |
tumor markers, biological - analysis |
14 |
tumor suppressor protein p53 - metabolism |
14 |
vegf |
14 |
ablation |
13 |
advanced hcc |
13 |
akt |
13 |
allergology and immunology |
13 |
anorectal malformation |
13 |
antineoplastic agents - pharmacology |
13 |
cadherins - metabolism |
13 |
cancer invasion |
13 |
cancer susceptibility genes |
13 |
cell division |
13 |
cell nucleus - metabolism |
13 |
child-pugh a |
13 |
chromosome 10q |
13 |
chromosome deletion |
13 |
cyclin-dependent kinase inhibitor p16 - genetics - metabolism |
13 |
cyclooxygenase-2 |
13 |
deep learning |
13 |
dna |
13 |
early-age onset |
13 |
enzyme activation |
13 |
epstein-barr virus |
13 |
esophageal squamous cell carcinoma (escc) |
13 |
fluorescent antibody technique |
13 |
follow up |
13 |
gene function |
13 |
glioblastoma |
13 |
gwas |
13 |
heterogeneity |
13 |
hong kong chinese |
13 |
hypermethylation |
13 |
intercellular communication |
13 |
l-lactate dehydrogenase - blood |
13 |
liver disease |
13 |
liver neoplasms - genetics - metabolism |
13 |
liver transplantation - immunology |
13 |
living donor liver transplant |
13 |
local recurrence |
13 |
loss of heterozygosity |
13 |
lymph node metastasis |
13 |
lymphocyte subsets |
13 |
membrane proteins - genetics - metabolism |
13 |
micrornas - genetics |
13 |
molecular biology |
13 |
mst1r |
13 |
neck dissection |
13 |
neoplasm proteins - genetics - metabolism |
13 |
neoplasm recurrence, local |
13 |
obesity |
13 |
polymorphism |
13 |
postoperative care |
13 |
prevention |
13 |
rna, messenger - analysis |
13 |
staging |
13 |
stomach neoplasms - genetics - pathology |
13 |
therapeutics |
13 |
thoracoscopy |
13 |
tissue array analysis |
13 |
tissue donors |
13 |
trans-activators |
13 |
tumor markers, biological - genetics |
13 |
tumor markers, biological - genetics - metabolism |
13 |
tumor-initiating cells |
13 |
type 2 diabetes mellitus |
13 |
validity |
13 |
vascular surgical procedures - methods |
13 |
acute hepatitis |
12 |
ampk |
12 |
apobec-mediated signature |
12 |
arginine methylation |
12 |
autophagy |
12 |
berberine |
12 |
bile ducts - surgery |
12 |
bronchiectasis |
12 |
cancer cell culture |
12 |
cancer metastasis |
12 |
cancer recurrence |
12 |
carcinoma, hepatocellular - surgery |
12 |
carcinoma, squamous cell - genetics |
12 |
carrier proteins - genetics |
12 |
carrier state |
12 |
cell transformation, neoplastic - genetics |
12 |
chemotherapy, adjuvant |
12 |
chromosome aberration |
12 |
chronic obstructive lung disease |
12 |
convalescence |
12 |
curcumin |
12 |
cyclin d1 - genetics |
12 |
dna-binding proteins - metabolism |
12 |
enzyme inhibitors - therapeutic use |
12 |
ephrin-a2 - genetics |
12 |
epigenetics |
12 |
esophageal carcinoma |
12 |
gene expression regulation - physiology |
12 |
gene expression regulation, neoplastic - drug effects |
12 |
gwa |
12 |
heme oxygenase-1 |
12 |
hepaticojejunostomy |
12 |
hepatitis b - complications |
12 |
homozygote |
12 |
human tissue |
12 |
indocyanine green |
12 |
inguinal hernia |
12 |
karyotyping |
12 |
laparoscopic |
12 |
laparoscopic resection |
12 |
liver - metabolism - pathology |
12 |
liver diseases - surgery |
12 |
liver neoplasms |
12 |
liver neoplasms - surgery |
12 |
living donor |
12 |
logistic models |
12 |
lupus erythematosus, systemic - genetics |
12 |
management |
12 |
meld |
12 |
mice, transgenic |
12 |
micrornas - genetics - metabolism |
12 |
microsatellite repeats - genetics |
12 |
mirna |
12 |
mtor |
12 |
myocardial infarction |
12 |
nasopharyngeal cancer |
12 |
nasopharyngeal carcinoma (npc) |
12 |
nasopharyngeal neoplasms - genetics |
12 |
neuroblastoma |
12 |
oncogene proteins - genetics |
12 |
organ size |
12 |
overall survival |
12 |
oxidative stress |
12 |
pediatric liver transplantation |
12 |
postoperative complications - prevention & control |
12 |
preoperative care |
12 |
promoter hypermethylation |
12 |
questionnaires |
12 |
receptor protein-tyrosine kinases - genetics - metabolism |
12 |
recurrent laryngeal nerve |
12 |
registries |
12 |
reliability |
12 |
responsiveness |
12 |
reverse transcriptase inhibitors - therapeutic use |
12 |
safety |
12 |
sars-cov-2 rbd igg |
12 |
secondary prevention |
12 |
silver nanoparticles |
12 |
sle |
12 |
somatic mutation landscape |
12 |
species index: animalia |
12 |
stress |
12 |
surveillance |
12 |
t cell response |
12 |
therapeutic target |
12 |
thyroiditis |
12 |
tissue distribution |
12 |
tissue microarray |
12 |
transcriptional activation |
12 |
tumor marker |
12 |
tumor necrosis factor-alpha - genetics - metabolism |
12 |
tumor stem cell assay |
12 |
tumor suppressor protein p53 - genetics - metabolism |
12 |
uhrf1bp1 |
12 |
vascular endothelial growth factor |
12 |
wnt signaling pathway |
12 |
abdominal aortic aneurysm |
11 |
acute flare |
11 |
adaptor proteins, signal transducing - genetics - metabolism |
11 |
afp |
11 |
alpps |
11 |
animal model |
11 |
anti-bacterial agents - therapeutic use |
11 |
antigens, cd3 - genetics |
11 |
anxiety |
11 |
apoptosis - genetics |
11 |
bat |
11 |
biological markers - blood |
11 |
blood loss, surgical |
11 |
blood vessel prosthesis implantation |
11 |
cadherins - genetics - metabolism |
11 |
carcinoma, hepatocellular - enzymology - pathology |
11 |
carcinoma, hepatocellular - etiology - genetics - metabolism |
11 |
carcinoma, hepatocellular - genetics - metabolism - pathology - virology |
11 |
carcinoma, hepatocellular - mortality - therapy |
11 |
catheter ablation |
11 |
cd247 |
11 |
cell adhesion molecules - genetics - metabolism |
11 |
cell cycle |
11 |
cell migration |
11 |
cell transformation, neoplastic |
11 |
cercopithecus aethiops |
11 |
chemoprevention |
11 |
cho cells - virology |
11 |
confidence intervals |
11 |
cos cells |
11 |
cox-2 |
11 |
cricetulus |
11 |
cross-sectional studies |
11 |
cyclin d1 - biosynthesis - genetics |
11 |
decompensation |
11 |
diagnosis and prognosis |
11 |
education |
11 |
endovascular |
11 |
ethnic group |
11 |
feces analysis |
11 |
gastrointestinal bleeding |
11 |
gene amplification |
11 |
gene mapping |
11 |
genes |
11 |
genes, p53 |
11 |
genetic predisposition |
11 |
hepatitis b infection |
11 |
hepatoblastoma |
11 |
hernia |
11 |
high-intensity focused ultrasound |
11 |
homeodomain proteins - genetics |
11 |
hoxb5 |
11 |
immunoprecipitation |
11 |
immunosuppressive agents - pharmacology |
11 |
in situ hybridization |
11 |
inhibitor of differentiation protein 1 |
11 |
intestine, small - physiology |
11 |
kw034 - copy number/structural variation |
11 |
lamivudine - therapeutic use |
11 |
laparoscopic surgery |
11 |
lectins, c-type - genetics - metabolism |
11 |
liver neoplasms - enzymology - pathology |
11 |
liver neoplasms - genetics - metabolism - pathology - virology |
11 |
liver neoplasms - mortality - therapy |
11 |
liver transplantation - statistics & numerical data |
11 |
lung - physiology - virology |
11 |
lupus erythematosus, systemic - genetics - immunology |
11 |
macrophage |
11 |
metastases |
11 |
neural crest |
11 |
nidogen 1 |
11 |
nidogen-2 (nid2) |
11 |
non-coding rna |
11 |
nucleotide sequence |
11 |
organoid |
11 |
paraganglioma |
11 |
pediatric |
11 |
peptidylprolyl isomerase - biosynthesis - genetics |
11 |
peritoneal dialysis |
11 |
pre‐metastatic niche |
11 |
proteasome endopeptidase complex - metabolism |
11 |
pten |
11 |
rats, inbred lew |
11 |
receptors, cell surface - genetics - metabolism |
11 |
repressor proteins |
11 |
sars coronavirus |
11 |
sars virus - isolation and purification - pathogenicity |
11 |
sars virus - metabolism - pathogenicity |
11 |
severe acute respiratory syndrome - epidemiology - genetics |
11 |
spectrometry, mass, matrix-assisted laser desorption-ionization |
11 |
stomach neoplasms - genetics - metabolism |
11 |
survival outcomes |
11 |
systemic lupus erythematosus |
11 |
thyroid function tests |
11 |
thyroid gland |
11 |
tissue donors - supply and distribution |
11 |
trans-activators - genetics |
11 |
tumor necrosis factor receptor 1 |
11 |
tumor suppressor proteins - genetics - metabolism |
11 |
vaccination |
11 |
vero cells - virology |
11 |
whole exome sequencing |
11 |
wound healing - drug effects |
11 |
xenograft model antitumor assays |
11 |
actins - metabolism |
10 |
adeno-associated virus |
10 |
adipocyte |
10 |
adjuvant therapy |
10 |
advanced cancer |
10 |
alpha-fetoprotein |
10 |
aneurysm |
10 |
angioplasty |
10 |
antigens, cd - genetics - metabolism |
10 |
arhgap fusions |
10 |
b-type natriuretic peptide |
10 |
bevacizumab |
10 |
biliary anastomotic stricture |
10 |
biliary obstruction |
10 |
biobank |
10 |
brca1 protein - genetics |
10 |
cadherins - blood |
10 |
cancer cell |
10 |
cancer chemotherapy |
10 |
cardiac troponin |
10 |
caspase 3 |
10 |
chronic hepatitis b |
10 |
colonoscopy |
10 |
confirmatory factor analysis |
10 |
coronavirus - immunology - pathogenicity - physiology |
10 |
coronavirus infections - immunology - virology |
10 |
cyclin d1 - metabolism |
10 |
cyclosporine - therapeutic use |
10 |
cytokine and chemokine response |
10 |
cytokines - biosynthesis - immunology |
10 |
cytokines - genetics - metabolism |
10 |
diagnostic imaging |
10 |
down-regulation - drug effects |
10 |
drug administration schedule |
10 |
drug screening |
10 |
ebv genome |
10 |
endocrinology |
10 |
endovascular procedures |
10 |
endovascular treatment |
10 |
epithelial cells - drug effects - pathology |
10 |
esophageal neoplasms - genetics |
10 |
exome |
10 |
extracellular matrix protein |
10 |
extracellular signal-regulated map kinases - metabolism |
10 |
fhl2 |
10 |
fibroblast growth factor |
10 |
fistula |
10 |
gastroesophageal reflux |
10 |
gene deletion |
10 |
genes, p53 - genetics |
10 |
genetic testing |
10 |
genetics |
10 |
germ-line mutation |
10 |
glioma |
10 |
hepatitis b virus - physiology |
10 |
hepatocellular |
10 |
hscr |
10 |
hypothyroidism |
10 |
imaging |
10 |
in situ nick-end labeling |
10 |
intercellular signaling peptides and proteins - metabolism |
10 |
interleukin-6 |
10 |
intracellular signaling peptides and proteins |
10 |
lamivudine |
10 |
lipocalin-2 |
10 |
liver - drug effects - injuries - metabolism |
10 |
liver cell carcinoma |
10 |
liver transplantation - methods - statistics and numerical data |
10 |
living donor liver transplantation |
10 |
living donors - supply and distribution |
10 |
loh |
10 |
mapk |
10 |
mers-cov |
10 |
mice, inbred c57bl |
10 |
microcirculation |
10 |
microscopy, electron |
10 |
milan criteria |
10 |
molecular pathology |
10 |
neovascularization, pathologic - prevention & control |
10 |
neutralizing antibody |
10 |
new technology |
10 |
nf-kappa b - metabolism |
10 |
oesophagectomy |
10 |
organoid culture |
10 |
overexpression |
10 |
phosphatidylinositol 3-kinases - metabolism |
10 |
phosphorylation - drug effects |
10 |
plasma |
10 |
pneumonia, viral - immunology - virology |
10 |
polymorphism, genetic - genetics |
10 |
positron-emission tomography |
10 |
postoperative period |
10 |
protein binding |
10 |
protein isoforms |
10 |
proto-oncogene proteins c-myc - biosynthesis - genetics |
10 |
proto-oncogene proteins c-ret |
10 |
proto-oncogene proteins c-ret - genetics |
10 |
rare complex disease |
10 |
receptor protein-tyrosine kinases - genetics |
10 |
receptors, endothelin - genetics |
10 |
reconstructive surgical procedures - methods |
10 |
referral and consultation |
10 |
renal transplantation |
10 |
reverse transcriptase polymerase chain reaction - methods |
10 |
rhoa mutations |
10 |
risk prediction |
10 |
scarce deceased donors |
10 |
sequence homology, amino acid |
10 |
signal transduction - drug effects |
10 |
signaling |
10 |
sonic hedgehog |
10 |
sphingosine - analogs & derivatives |
10 |
structure-activity relationship |
10 |
surgery medical sciences |
10 |
telomerase |
10 |
traditional chinese medicine |
10 |
trans-activators - genetics - metabolism |
10 |
transcriptome sequencing |
10 |
transplantation, homologous |
10 |
tumor growth |
10 |
tumor markers, biological - metabolism |
10 |
tumor suppression |
10 |
undergraduate |
10 |
up-regulation - genetics |
10 |
vascular endothelial growth factor a - blood |
10 |
vascular endothelial growth factors |
10 |
venous infiltration |
10 |
viral replication |
10 |
virus replication - physiology |
10 |
11c-acetate |
9 |
adam proteins - biosynthesis - genetics - metabolism |
9 |
age-stratified |
9 |
airway organoid |
9 |
alpha-fetoproteins - analysis |
9 |
alternative splicing |
9 |
amino acid substitution |
9 |
anastomosis, surgical - adverse effects |
9 |
anosmia |
9 |
antibody therapy |
9 |
antigens, cd44 - genetics - metabolism |
9 |
aortic aneurysm |
9 |
asian-specific |
9 |
bile |
9 |
bilirubin - blood |
9 |
bioinformatics |
9 |
brca2 |
9 |
breath tests |
9 |
cancer screening |
9 |
capecitabine |
9 |
carcinoma, hepatocellular - pathology - surgery |
9 |
carcinoma, hepatocellular - virology |
9 |
cell adhesion molecules |
9 |
cell cycle proteins - metabolism |
9 |
cell division - drug effects |
9 |
cell movement - drug effects |
9 |
chromosomes, human, pair 13 - genetics |
9 |
contrast ct |
9 |
cost-benefit analysis |
9 |
dna, viral - analysis |
9 |
drug combinations |
9 |
dual specificity phosphatase 6 - genetics - metabolism |
9 |
dual-specificity phosphatase 6 (dusp6) |
9 |
ebv |
9 |
electrophoresis, gel, two-dimensional |
9 |
endothelial cells - cytology |
9 |
epigenesis, genetic |
9 |
epithelial cells - pathology |
9 |
esophageal neoplasms - blood supply - enzymology - genetics |
9 |
esophageal neoplasms - genetics - pathology |
9 |
evaluation studies as topic |
9 |
exome-chip association analysis |
9 |
expression quantitative trait loci |
9 |
fact-c |
9 |
feasibility studies |
9 |
fibroblasts |
9 |
fty720 |
9 |
gastric carcinoma |
9 |
gene duplication |
9 |
gene knockdown techniques |
9 |
genetic markers - genetics |
9 |
genome, human |
9 |
gpx3 |
9 |
graft survival - drug effects |
9 |
haplotypes - genetics |
9 |
hepatology |
9 |
herpesvirus 4, human - genetics |
9 |
hif-1α |
9 |
hifu |
9 |
hipsc-mscs |
9 |
hospitals, university |
9 |
hsp70 heat-shock proteins - metabolism |
9 |
iatrogenic disease |
9 |
immunity |
9 |
immunoglobulin heavy chains - genetics |
9 |
infectivity |
9 |
influenza virus |
9 |
informed consent |
9 |
intracellular signaling peptides and proteins - genetics - metabolism |
9 |
invasiveness |
9 |
ischemia-reperfusion injury |
9 |
kasai operation |
9 |
ligation |
9 |
liver - anatomy & histology |
9 |
liver circulation - physiology |
9 |
liver diseases - epidemiology |
9 |
liver failure - etiology - surgery |
9 |
liver failure - surgery |
9 |
liver injury |
9 |
liver neoplasms - virology |
9 |
liver transplantation - mortality |
9 |
luciferases - metabolism |
9 |
lymph nodes - pathology |
9 |
lymphoma, follicular - genetics - pathology |
9 |
lymphoma, large b-cell, diffuse - genetics - pathology |
9 |
machine learning |
9 |
macrophages |
9 |
models, animal |
9 |
nash |
9 |
nasopharyngeal neoplasms - blood supply - enzymology - genetics |
9 |
natural selection |
9 |
neck |
9 |
neoadjuvant chemoradiotherapy |
9 |
neoplasm staging - methods |
9 |
nitric oxide |
9 |
nodal metastasis |
9 |
nomogram |
9 |
non-invasive treatment |
9 |
non-viral liver disease |
9 |
olfactory dysfunction |
9 |
oncogene proteins - genetics - metabolism |
9 |
oral cancer |
9 |
palliative care - methods |
9 |
pancreatic cancer |
9 |
pancreaticoduodenectomy |
9 |
pax4 |
9 |
postoperative complications - classification - epidemiology |
9 |
prediction |
9 |
proctology |
9 |
proliferating cell nuclear antigen |
9 |
propylene glycols - pharmacology |
9 |
protein transport |
9 |
proteins - metabolism |
9 |
proximal differentiation |
9 |
radioactive iodine |
9 |
rare variants |
9 |
right liver graft |
9 |
rna, neoplasm - genetics |
9 |
salvage surgery |
9 |
screening |
9 |
sepsis |
9 |
sequence homology, nucleic acid |
9 |
smell impairment |
9 |
stereotactic body radiation therapy |
9 |
stomach neoplasms - genetics - metabolism - pathology |
9 |
swine |
9 |
temozolomide |
9 |
thyroid nodule |
9 |
toxicity |
9 |
travel history |
9 |
tumor heterogeneity |
9 |
tumourigenesis |
9 |
ultrasonography, interventional |
9 |
xenograft |
9 |
acetic acid c 11 |
8 |
acute pancreatitis |
8 |
adenocarcinoma |
8 |
adverse events |
8 |
aganglionosis |
8 |
age |
8 |
alanine transaminase - blood |
8 |
anastomosis, surgical - methods |
8 |
antineoplastic agents, hormonal - therapeutic use |
8 |
antiviral agents - adverse effects - therapeutic use |
8 |
antiviral therapy |
8 |
apoptosis - physiology |
8 |
attitude of health personnel |
8 |
bile duct |
8 |
bile leak |
8 |
biliary atresia - complications - surgery |
8 |
biliary complications |
8 |
brca1 |
8 |
burns |
8 |
cadaver donor |
8 |
cancer metabolism |
8 |
carbon tetrachloride |
8 |
carcinoma - genetics |
8 |
carcinoma, hepatocellular - complications/diagnosis - surgery |
8 |
carcinoma, hepatocellular - enzymology - genetics |
8 |
carcinoma, hepatocellular - genetics - metabolism - pathology - secondary |
8 |
carcinoma, hepatocellular - metabolism - pathology - secondary |
8 |
carcinoma, hepatocellular - surgery - virology |
8 |
carcinoma, hepatocellular - therapy |
8 |
cardiac function |
8 |
carotid endarterectomy |
8 |
catheter ablation - methods |
8 |
cell adhesion molecules - genetics - physiology |
8 |
cell cycle - drug effects |
8 |
cell differentiation - physiology |
8 |
cell division - physiology |
8 |
cell membrane - metabolism |
8 |
cell motility |
8 |
chemoembolization, therapeutic - adverse effects - mortality |
8 |
chemokine cxcl1 - physiology |
8 |
child-pugh b |
8 |
cholestasis - etiology |
8 |
chromosome 8p |
8 |
circulating mirna |
8 |
circulating tumor cells |
8 |
cisplatin - therapeutic use |
8 |
clinical trials as topic |
8 |
cloning, molecular |
8 |
codon |
8 |
complications of liver transplantation |
8 |
contrast media |
8 |
craniofacial resection |
8 |
cutoff |
8 |
cyclin a2 |
8 |
cyclin d1 |
8 |
cyclooxygenase 2 |
8 |
deceased donor liver transplantation |
8 |
depression |
8 |
diarrhoea |
8 |
differential expression |
8 |